PROS1 and cancer: However, several studies have illustrated that Apo2L/TRAIL resistance in cancer cell lines involves the expression of the anti-apoptotic protein c-FLIP and down-regulation of the pro-apoptotic protein caspase-8 [20], [27], [45].